发明申请
US20060264425A1 Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
失效
新型邻氨基苯甲酰胺吡啶脲作为血管内皮生长因子（VEGF）受体激酶抑制剂
- 专利标题： Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
- 专利标题（中）： 新型邻氨基苯甲酰胺吡啶脲作为血管内皮生长因子（VEGF）受体激酶抑制剂
-
申请号： US11265516申请日： 2005-11-03
-
公开(公告)号： US20060264425A1公开(公告)日： 2006-11-23
- 发明人: Rolf Bohlmann , Martin Haberey , Andreas Huth , Stuart Ince , Martin Krueger , Karl-Heinz Thierauch , Holger Hess-Stumpp
- 申请人： Rolf Bohlmann , Martin Haberey , Andreas Huth , Stuart Ince , Martin Krueger , Karl-Heinz Thierauch , Holger Hess-Stumpp
- 优先权： EP04090418.7 20040311
- 主分类号： A61K31/541
- IPC分类号： A61K31/541 ; A61K31/5377 ; A61K31/496 ; C07D417/14 ; C07D413/14 ; C07D403/14
摘要：
The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
公开/授权文献
信息查询
